跳至主要内容
临床试验/NCT06158074
NCT06158074已完成不适用

Efficacy of Electrical Pudendal Nerve Stimulation and Sacral Neuromodulation in Treating Non-obstructive Neurogenic Urinary Retention: A Nonrandomized Clinical Trial

Shanghai Institute of Acupuncture, Moxibustion and Meridian2 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2024年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
70
试验地点
2
主要终点
Percent change in pre-post treatment post-voiding residual urine volume (PVR )

研究概览

简要总结

To observe the clinical effects and make a comparative study between efficacy of electrical pudendal nerve stimulation (EPNS) and sacral neuromodulation (SNM) , evaluate the advantages of EPNS in the treatment of neurogenic non-obstructive urinary retention, and provide a new method for the treatment of the disease.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Non-mechanical obstructive urinary retention occurs following relevant neurological system disorders (spinal cord injury, spina bifida,myelitis, cervical/thoracic disk disease, lesion following spinal anesthesia/spine surgery,lumbar/sacral spine intervertebral disc diseases, spinal stenosis, iatrogenic pelvic nerve lesions, sacral agenesis, peripheral neuropathy due to diabetes mellitus).
  • With normal upper urinary tract function.
  • Other therapies and medications potentially affecting the assessment of this therapy have been discontinued for at least two weeks before the interventional procedure.
  • Patient with good compliance who is capable of cooperating with the follow-up requirements

排除标准

  • Patients with any suprapontine and pontine lesions
  • Pregnant or lactating women
  • Individuals whose symptoms show significant improvement after pharmaceutical and adjunctive therapy
  • Individuals with concurrent acute or chronic prostatitis, prostate cancer, or conditions such as bladder neck stenosis, urethral stricture, or urethral injury
  • High pathological risk factors (e.g., lymph node metastasis, resection margin involvement, bulky tumors)
  • Individuals with concomitant obstructive urinary retention

结局指标

主要结局

Percent change in pre-post treatment post-voiding residual urine volume (PVR )

时间窗: baseline (T0), mid-treatment (T1; after 6 EPNS sessions or 2 weeks of SNM), and (T2; after 12 EPNS sessions or 4 weeks of SNM)

Bladder PVR is measured by ultrasound.Percent change in pre-post treatment PVR is calculated as (baseline PVR - post-treatment PVR) / baseline PVR × 100%.

次要结局

  • Absolute post-voiding residual volume (PVR) at the end of treatment; International Consultation on Incontinence Questionnaire-Lower Urinary Tract Symptoms (ICIQ-LUTS) and the quality of life (ICIQ-LUTSqol) score.(Mid-treatment (T1; after 6 EPNS sessions or 2 weeks of SNM), and (T2; after 12 EPNS sessions or 4 weeks of SNM))

研究者

发起方
Shanghai Institute of Acupuncture, Moxibustion and Meridian
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Efficacy of Electrical Pudendal Nerve Stimulation... | 临床试验